SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
WillScot Holdings held its Annual Meeting of stockholders and voted on five proposals: election of nine directors, ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, frequency of future advisory votes on compensation, and approval of the 2026 Incentive Award Plan. All proposals passed with substantial majorities.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Astera Labs' 2026 Annual Stockholders Meeting held on June 4, 2026. The filing reports vote tabulations for four proposals: election of three Class II directors, auditor ratification, say-on-pay advisory vote, and say-on-frequency advisory vote, with specific vote counts for each proposal. This is a quintessential Item 5.07 disclosure and is material to investors as it documents the outcomes of key corporate governance matters.
View raw filing on EDGAR →Root, Inc. held its 2026 Annual Meeting of Stockholders and disclosed voting results on four proposals: election of Class III directors (Lawrence Hilsheimer, Alexander Timm, Douglas Ulman), ratification of Deloitte & Touche LLP as independent auditor, advisory approval of named executive officer compensation, and approval of a certificate amendment regarding officer exculpation.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Cipher Digital's June 2, 2026 Annual Meeting of Stockholders, filed under Item 5.07. The filing reports voting outcomes for three proposals: election of directors (Thomas Duda, James Newsome, Wesley Williams), ratification of CBIZ CPAs P.C. as independent auditor, and advisory approval of executive compensation. All three proposals passed with substantial majorities, and the disclosure includes vote counts and percentages as required by Item 5.07.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Oklo Inc.'s 2026 Annual Meeting of Stockholders held on June 3, 2026. The filing reports voting outcomes for two matters: (1) election of Class II directors (Caroline DeWitte, Richard W. Kinzley, and Dr. Mark Peters) and (2) ratification of Deloitte & Touche LLP as independent auditor. This is a textbook Item 5.07 disclosure and is material as it reflects stockholder approval of board composition and auditor selection.
View raw filing on EDGAR →Item 5.07 discloses the results of NewLake Capital Partners' Annual Meeting of Stockholders held on June 4, 2026, including the election of seven directors to the Board and ratification of CBIZ CPAs P.C. as independent auditor. The filing presents detailed voting tallies for each director nominee and the auditor ratification, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of D-Wave's June 4, 2026 annual meeting of stockholders. The filing presents voting tallies for four proposals: election of Class I directors (Alan E. Baratz and Sharon Holt), advisory Say-on-Pay vote, Say-on-Frequency vote (one year prevailed), and ratification of Grant Thornton LLP as auditor. The Board's subsequent actions (election of Sharon Holt as Chair, committee reassignments) flow directly from these shareholder votes and board determinations, making this a material governance event.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of W. R. Berkley Corporation's Annual Meeting of Stockholders held on June 3, 2026, including voting outcomes for the election of five directors, a non-binding say-on-pay vote on named executive officer compensation, and ratification of KPMG LLP as independent auditor. The filing presents detailed vote tallies (For, Against, Abstain, Broker Non Votes) for each matter, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →Walmart held its annual shareholder meeting on June 5, 2026, with voting results including approval of all 11 director nominees, ratification of Ernst & Young LLP as independent auditors, advisory approval of named executive officer compensation, approval of a Charter Amendment limiting officer liability, and rejection of four shareholder proposals.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from UnitedHealth's June 1, 2026 Annual Meeting of Shareholders under Item 5.07. The filing reports results on four matters: election of nine directors (all approved with strong majorities ranging from 89.68% to 98.96%), a non-binding advisory vote on executive compensation (82.74% approval), ratification of Deloitte & Touche LLP as auditor (95.00% approval), and a shareholder proposal on board chair independence (20.24% approval, not approved). These results are material to investors as they confirm the composition of the board and validate management's compensation and auditor selection.
View raw filing on EDGAR →This Item 5.07 disclosure presents the final voting results from Granite Construction's Annual Meeting held June 4, 2026, covering three matters: election of three directors (Hernandez, Larkin, and Mastin), advisory vote on named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing explicitly states the vote tallies and confirms the outcomes of each proposal, which is the core purpose of shareholder_vote_results classification.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the Annual Meeting of Stockholders held on June 4, 2026, reporting the election of directors (Kay M. Dorow and Steven Haen) and ratification of the independent auditor (Plante Moran, PLLC). The filing directly corresponds to Item 5.07 and presents final voting tallies for each matter submitted to stockholders, which is material to investors' understanding of corporate governance and audit oversight.
View raw filing on EDGAR →LifeCore Biomedical held its Annual Meeting of Stockholders on June 4, 2026, with voting results on four proposals: election of nine directors, ratification of KPMG LLP as auditor, advisory approval of named executive officer compensation, and approval of the 2026 Stock Incentive Plan. All vote tallies (For, Against, Abstain, and Broker Non-Votes) are disclosed.
View raw filing on EDGAR →OneSpan held its 2026 annual meeting of stockholders on June 5, 2026, with shareholders voting on five proposals: election of seven directors, advisory approval of named executive officer compensation, frequency of future advisory votes on compensation, amendment to the 2019 Omnibus Incentive Plan to increase available shares by 2,000,000, and ratification of KPMG LLP as independent auditor. All five proposals passed.
View raw filing on EDGAR →Netflix held its annual meeting of stockholders on June 4, 2026, with detailed vote results disclosed for the election of 12 directors, ratification of auditors, advisory vote on executive compensation, and four non-binding stockholder proposals.
View raw filing on EDGAR →Lifeloc Technologies held its Annual Meeting of Shareholders on June 3, 2026, with voting results on four matters: election of five directors, ratification of independent auditor (Assure CPA), advisory vote on executive compensation, and approval of amended articles of incorporation.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of Ur-Energy Inc.'s Annual General and Special Meeting of Shareholders held on June 4, 2026, including voting outcomes on five proposals: election of eight directors (all elected with high approval rates), reappointment of BDO USA as auditors, advisory votes on executive compensation and say-when-on-pay frequency, and renewal of the stock option plan. The detailed vote tallies and shareholder participation (70.84% quorum) are material to investors assessing governance and capital allocation decisions.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes on four matters: election of eight directors (all approved by majority), appointment of PricewaterhouseCoopers LLP as independent auditor (97.38% approval), an advisory vote on named executive officer compensation (33.72% approval, notably not approved), and approval of Amendment No. 5 to the 2016 Stock Plan (90.76% approval). The disclosure includes vote counts and percentages for each proposal, which is the standard format for shareholder vote results.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Westrock Coffee's 2026 annual meeting of stockholders held on June 5, 2026, including the election of four Class I directors (Mark A. Edmunds, Joe T. Ford, Kenneth M. Parent, and Oluwatoyin Umesiri) and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing directly matches the shareholder_vote_results event type and is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →Omega Healthcare Investors held its 2026 Annual Meeting of Shareholders on June 5, 2026. Shareholders voted on and approved three proposals: election of eight directors, ratification of Ernst & Young LLP as independent auditor, and an advisory vote on executive compensation.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Ribbon Communications' annual meeting of stockholders held on June 3, 2026. The filing presents voting results for three proposals: election of nine directors, ratification of Deloitte & Touche LLP as independent auditor, and an advisory vote on named executive officer compensation. All three proposals passed with substantial majorities, representing routine shareholder governance matters that are material to investors' understanding of corporate governance and board composition.
View raw filing on EDGAR →Shareholders voted at the 2026 Annual Meeting of Stockholders held on June 4, 2026, approving the election of seven directors, the advisory approval of executive compensation, and the ratification of Ernst & Young LLP as independent auditor.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Ladder Capital's June 4, 2026 annual meeting of stockholders. The filing reports voting outcomes for two proposals: (1) re-election of Brian Harris and Mark Alexander as Class III Directors, and (2) ratification of Ernst & Young LLP as independent auditor for 2026. The detailed vote tallies (votes for, votes withheld/against, broker non-votes, and abstentions) are presented in tabular form, which is the standard format for Item 5.07 disclosures.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the Annual Meeting held on June 4, 2026, covering three proposals: election of three Class II Directors (Laura Brege, Badreddin Edris, and Jonathan Root), ratification of KPMG LLP as independent auditor, and advisory vote on named executive officer compensation. The filing directly matches Item 5.07 requirements and presents final vote tallies for each proposal.
View raw filing on EDGAR →Consolidated Water Co. Ltd. held its Annual General Meeting on June 1, 2026, at which shareholders voted on eight proposals including director elections, approval of the 2027 Employee Stock Incentive Plan, authorization of share capital increases, amendments to the Memorandum and Articles of Association, an advisory vote on executive compensation, and ratification of the independent auditor. All proposals passed with substantial majorities.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of PTC Therapeutics' Annual Meeting held June 2, 2026, including election of four Class I directors, ratification of Ernst & Young LLP as independent auditor, and approval of a non-binding advisory vote on named executive officer compensation. The filing presents vote tallies for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from nLIGHT's 2026 annual meeting held on June 5, 2026. The filing reports voting outcomes on three proposals: election of a Class II director (Geoffrey Moore), ratification of KPMG LLP as independent auditor, and an advisory vote on named executive officer compensation. The compensation proposal notably failed, with 24.6 million votes against versus 15.8 million for—a material governance signal that would affect investor assessment of management alignment.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of Navient Corporation's 2026 Annual Meeting of Shareholders held on June 4, 2026, including voting outcomes on four proposals: election of six directors, ratification of KPMG LLP as independent auditor, advisory approval of executive compensation, and say-on-pay frequency. The detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal are the core disclosure, making this a textbook shareholder_vote_results event.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of Prairie Operating Co.'s 2026 Annual Meeting of Stockholders held on June 3, 2026, including voting outcomes for two proposals: election of four directors (Richard N. Frommer, Jonathan Gray, Stephen Lee, and Erik Thoresen) and ratification of Deloitte & Touche LLP as the independent auditor. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) are the core disclosure required by Item 5.07, making this a clear shareholder vote results event that is material to investors assessing board composition and auditor selection.
View raw filing on EDGAR →Stockholders approved a reverse stock split proposal at a Special Meeting held on June 1, 2026, with the Board authorized to implement a 1-for-2 to 1-for-25 reverse stock split ratio at its discretion. The Board subsequently approved and announced implementation of a 1-for-6 reverse stock split, effective June 12, 2026.
View raw filing on EDGAR →Seadrill held its Annual General Meeting on June 3, 2026, at which shareholders voted on and approved six proposals: board size determination, re-election of nine directors, appointment of PwC US as auditor, director remuneration approval, advisory vote on named executive officer compensation, and Amendment No. 1 to the 2022 Management Incentive Plan.
View raw filing on EDGAR →This Item 5.07 filing discloses the final results of three shareholder votes at Zumiez's Annual Meeting: election of three directors (Thomas D. Campion, Liliana Gil Valletta, Carmen R. Bauza), an advisory vote on executive compensation, and ratification of Baker Tilly US, LLP as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core disclosure, which is the defining characteristic of shareholder_vote_results.
View raw filing on EDGAR →FTI Consulting held its 2026 Annual Meeting of Shareholders on June 3, 2026, with voting results on three proposals: election of eight directors, ratification of KPMG LLP as independent auditor, and an advisory vote on named executive officer compensation.
View raw filing on EDGAR →MBX Biosciences held its 2026 Annual Meeting on June 4, 2026, at which stockholders approved the election of two Class II directors (Patrick J. Heron and Edward T. Mathers) for three-year terms and ratified Ernst & Young LLP as the company's independent auditor.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from PMV Pharmaceuticals' June 4, 2026 Annual Meeting. The filing reports voting outcomes on three proposals: election of Class III directors (David H. Mack and Laurie Stelzer), non-binding advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (FOR, AGAINST, WITHHELD, ABSTAIN, BROKER NON-VOTE) are the hallmark of shareholder meeting result disclosures and are material to investors assessing governance and board composition.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the June 4, 2026 annual meeting, covering three proposals: election of Class I directors (Joshua E. Schechter and Jill H. Bright), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The filing explicitly states voting tallies for each proposal, which is the hallmark of Item 5.07 shareholder_vote_results disclosures.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from GTJ REIT's Annual Meeting of Stockholders held on June 4, 2026, covering the election of three Class II directors (Paul Cooper, Louis Sheinker, and Stanley Perla) and ratification of Baker Tilly US, LLP as independent auditor. The filing directly matches Item 5.07 requirements and presents vote tallies for each proposal, making this a textbook shareholder_vote_results event that is material to investors assessing board composition and audit oversight.
View raw filing on EDGAR →Assembly Biosciences held its Annual Meeting of Stockholders on June 4, 2026, with shareholders voting on five proposals: election of nine directors, advisory vote on named executive officer compensation, ratification of Ernst & Young LLP as auditor, and approval of amendments to the 2018 Stock Incentive Plan and ESPP to increase reserved shares.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder meeting results held on June 3, 2026. The filing reports voting outcomes on four proposals: election of 11 directors, advisory vote on executive compensation, ratification of Deloitte & Touche LLP as auditor, and a shareholder proposal on written consent rights. The detailed vote tallies (For, Against, Abstentions, Broker Non-Votes) for each proposal are the core content of the filing.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Cardinal Infrastructure Group's 2026 Annual Meeting of Stockholders held on June 5, 2026. The filing reports the results of two proposals: (1) election of six directors with detailed vote tallies for each nominee, and (2) ratification of Grant Thornton LLP as independent auditor. Item 5.07 explicitly requires disclosure of shareholder vote results, and all directors and the auditor were approved by substantial majorities, making this a material governance event.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from the Annual Meeting of Shareholders held on June 3, 2026. The filing presents detailed voting tallies for three proposals: (i) election of ten directors, (ii) ratification of Deloitte & Touche LLP as independent auditor, and (iii) advisory vote on named executive officer compensation. All three proposals passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely upon to assess board composition and audit oversight.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from McGrath RentCorp's June 3, 2026 annual meeting, covering four proposals: director elections, stock incentive plan amendment, auditor ratification, and executive compensation approval. The filing presents vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the defining characteristic of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Outset Medical's Annual Meeting of Stockholders held on June 4, 2026. The filing presents voting results for three proposals: election of Class III directors (Brent D. Lang and Karen Prange), advisory approval of named executive officer compensation, and ratification of KPMG LLP as independent auditor. All three proposals passed with clear majorities, and the disclosure includes vote counts (For, Against, Abstain, Broker Non-Votes) for each matter.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Definitive Healthcare's 2026 Annual Meeting of Stockholders held on June 4, 2026. The filing presents voting results for four proposals: election of three Class II directors, ratification of Deloitte & Touche LLP as independent auditor, approval of a 15-million-share increase to the 2021 Equity Incentive Plan, and an advisory vote on named executive officer compensation. All proposals passed with substantial majorities, and the disclosure includes detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal as required by SEC rules.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Sana Biotechnology's 2026 annual meeting held on June 4, 2026. The filing reports voting outcomes for two proposals: (1) election of Class II directors (Hans E. Bishop, Robert Nelsen, and Alise S. Reicin, M.D.) and (2) ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (For, Against/Withheld, Abstain, and Broker Non-Votes) are presented in tabular form, which is the standard format for Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Sight Sciences' June 4, 2026 annual meeting of stockholders. The filing reports voting outcomes for two proposals: election of two Class II directors (Gerhard Burbach and Staffan Encrantz) and ratification of Deloitte & Touche LLP as independent auditor. The disclosure includes vote tallies, quorum information (76.2% attendance), and explicit statement that both proposals passed. This is a textbook Item 5.07 shareholder vote results disclosure, material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from KinderCare's 2026 Annual Meeting of Stockholders held on June 4, 2026. The filing reports voting outcomes on three proposals: election of directors (Michael Nuzzo, John T. Wyatt, and Jean Desravines), ratification of PwC as independent auditor, and advisory approval of named executive officer compensation. All proposals passed with substantial majorities, and the disclosure includes vote tallies (For/Against/Withhold/Abstain/Broker Non-Votes) for each matter, which is the hallmark of Item 5.07 shareholder vote results reporting.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Harmonic Inc.'s 2026 Annual Meeting held on June 4, 2026. The filing reports voting outcomes on five matters: election of seven directors, advisory approval of named executive officer compensation, frequency of future say-on-pay votes, amendment to the 2025 Equity Incentive Plan, and ratification of Ernst & Young LLP as independent auditor. All matters were approved by stockholders. This is material as it reflects stockholder governance decisions and approval of executive compensation and equity plan amendments.
View raw filing on EDGAR →Claros Mortgage Trust held its Annual Meeting on June 3, 2026, with stockholders voting on four proposals: election of nine directors, ratification of PricewaterhouseCoopers LLP as auditor, advisory approval of named executive officer compensation, and approval of amendments to the 2016 Incentive Award Plan. The amendments increase the share reserve by 6.5 million shares, expand ISO grants, extend the ISO grant period, and establish a $750,000 annual compensation cap for non-employee directors.
View raw filing on EDGAR →This is a Form 8-K Item 5.07 disclosure of shareholder voting results from the June 4, 2026 Annual Meeting of Stockholders. The filing reports final voting tallies for three matters: (1) election of seven directors, (2) advisory vote on named executive officer compensation, and (3) ratification of PricewaterhouseCoopers LLP as independent auditor. All three proposals passed with substantial majorities. This is a routine but material disclosure required by Item 5.07 of Form 8-K.
View raw filing on EDGAR →